Leading companies in the brain health supplements market are focused on increasing their reach across emerging markets by expanding their distribution networks and augmenting their manufacturing capabilities. Emerging markets in India and South Korea are expected to offer potential growth opportunities to key brain health supplement manufacturers in the future. This can be attributed to the availability of a large patient pool with the growing elderly population; the high prevalence of depression, anxiety, mood swings, and other mental & cognitive disorders; increasing levels of disposable income; and improving infrastructure in the healthcare sector. Asia Pacific has become a business-friendly and adaptable hub due to relatively less stringent regulations and data requirements. Further, high investments by governments in these countries in life science and health research favor the upgrading of facilities with the latest technologies. Thus, progressive healthcare sectors in developing countries are likely to favor the Asia Pacific brain health supplements market in the coming years.
The Asia Pacific brain health supplements market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in this region is attributed to the growing mental illness, surging geriatric population, and increasing product launches by key players. The rising awareness about mental health, coupled with the prevalence of mental health disorders, is bolstering the brain health supplements market in China.
The Asia Pacific brain health supplements market is segmented on the basis of product, application, dosage form, distribution channel, age category, and country.
Based on product, the Asia Pacific brain health supplements market is segmented into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment held the largest market share in 2022. Further, natural molecule is segmented as acetyl-carnitine, citicoline, huperzine-A, alpha GPC, docosahexaenoic acid (DHA), and others. Additionally, herbal extract is further segmented as ginseng, curcumin, lion's mane, ginkgo biloba, bacopa monnieri, and others. Further, vitamins & minerals is further sub-segmented as vitamins C & E, vitamin B complex, and others.
Based on application, the Asia Pacific brain health supplements market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held the largest market share in 2022.
Based on dosage form, the Asia Pacific brain health supplements market is segmented into capsules, tablets, and others. The others segment held the largest market share in 2022.
Based on distribution channel, the Asia Pacific brain health supplements market is segmented into supermarket and hypermarket, drug store, online, and others. The supermarket and hypermarket segment held the largest market share in 2022.
Based on age category, the Asia Pacific brain health supplements market is segmented into adults, children, and elderly. The adults segment held the largest market share in 2022.
The Asia Pacific brain health supplements market, by country, is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.
Danone SA; Unilever PLC; Purelife bioscience Co., Ltd.; and Harbin Pharmaceutical Group Co., Ltd. are the leading companies operating in the Asia Pacific brain health supplements market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,506.36 Million |
| Market Size by 2028 | US$ 3,049.40 Million |
| CAGR (2022 - 2028) | 12.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
The Asia Pacific Brain Health Supplements Market is valued at US$ 1,506.36 Million in 2022, it is projected to reach US$ 3,049.40 Million by 2028.
As per our report Asia Pacific Brain Health Supplements Market, the market size is valued at US$ 1,506.36 Million in 2022, projecting it to reach US$ 3,049.40 Million by 2028. This translates to a CAGR of approximately 12.5% during the forecast period.
The Asia Pacific Brain Health Supplements Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Brain Health Supplements Market report:
The Asia Pacific Brain Health Supplements Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Brain Health Supplements Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Brain Health Supplements Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Brain Health Supplements Market
